Viekira Pak is part of the Hepatitis C Protease / Nucleotide Polymerase / NS5A Inhibitor Combinations class and treats Hepatitis C. Hepatitis C protease inhibitors, nucleotide polymerase inhibitors, and NS5A inhibitors are used together to treat hepatitis C. They work by interfering with the virus's ability to multiply and by slowing down the growth of the cells. Viekira Pak is only available as a brand name drug.

With the Patient Assistance Program from HealthWell Foundation, contact the program to see how they can financially help you out.